Table 2. Number and percentage of subjects with anti-HbsAg ≥10 mIU/mL in children adolescent (group I).
| Description | 0118S (n=66) | 0218S (n=67) | 0318S (n=64) | Control (n=65) | p-valuea) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |||
| Anti-HbsAg ≥10 mIU/mL | 0.502 (pre) | |||||||||
| 1.000 (post) | ||||||||||
| No. (%SP) | 16 (24.24) | 166 (100.00) | 15 (22.39) | 66 (98.51) | 9 (14.06) | 64 (100.00) | 13 (20.00) | 65 (100.00) | ||
| (95% CI) | (0.146–0.364) | (0.946–1.000) | (0.131–0.342) | (0.920–1.000) | (0.066–0.250) | (0.944–1.000) | (0.111–0.318) | (0.946–1.000) | ||
Values are presented as number of available observations (%), unless otherwise stated.
HBsAg, hepatitis B surface antigen; %SP, seroprotection rate; CI, confidence interval.
a)p-value based on chi-square test/Fisher exact.